• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎合并艰难梭菌感染患者的临床结局。

Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.

机构信息

Department of Medicine, Division of Gastroenterology, Inflammatory Bowel Disease Center, Mount Sinai School of Medicine, New York, NY, USA.

出版信息

Dig Dis Sci. 2010 Feb;55(2):415-20. doi: 10.1007/s10620-009-0749-9. Epub 2009 Mar 3.

DOI:10.1007/s10620-009-0749-9
PMID:19255850
Abstract

BACKGROUND

The incidence of Clostridium difficile infection is increasing in the United States. The aim of our investigation is to compare short-term and long-term outcomes of patients admitted with an ulcerative colitis (UC) flare and co-existent C. difficile infection to those of non-infected patients.

METHODS

A historical cohort study was undertaken examining admissions at Mount Sinai Hospital between June 2004 and June 2005 using ICD-9 criteria for UC. Charts were abstracted for those patients for whom C. difficile testing was performed.

RESULTS

Of 288 admissions, 99 charts met the inclusion criteria. Fifty-two patients were C. difficile-negative and 47 were positive. Demographic data and laboratory values upon admission did not differ between the two groups. Patients who were C. difficile-positive had significantly more UC-related hospitalizations and emergency room visits in the year following initial admission (58 visits vs. 27, P = 0.001 and eight visits vs. 1 visit (P = 0.012), respectively). One year following the index admission, C. difficile patients had significantly higher rates of colectomy compared to C. difficile-negative patients (44.6% vs. 25%, P = 0.04). Length of hospitalization (11.7 vs. 11 days), use of cyclosporine therapy during index admission (48% vs. 47% of patients), and percentage requiring colectomy at initial admission (23.4% vs. 13.5%) did not reach statistical significance.

CONCLUSIONS

Our data suggest that patients presenting with a UC flare who are infected with C. difficile have worse long-term clinical outcomes than those that are C. difficile-negative. C. difficile testing should be performed for all patients presenting with UC flare. Further studies are warranted to elucidate how infection can alter the natural history of UC.

摘要

背景

在美国,艰难梭菌感染的发病率正在上升。我们的研究旨在比较患有溃疡性结肠炎(UC)发作和并存艰难梭菌感染的患者与未感染患者的短期和长期结局。

方法

采用回顾性队列研究,使用 ICD-9 标准对 2004 年 6 月至 2005 年 6 月期间在西奈山医院的住院患者进行检查。对接受艰难梭菌检测的患者的病历进行了摘录。

结果

在 288 例住院患者中,99 份病历符合纳入标准。52 例患者艰难梭菌检测结果为阴性,47 例为阳性。两组患者入院时的人口统计学数据和实验室值无差异。艰难梭菌阳性患者在初次入院后 1 年内 UC 相关住院和急诊就诊次数明显更多(58 次就诊 vs. 27 次,P = 0.001;8 次就诊 vs. 1 次就诊,P = 0.012)。在初次入院后 1 年,艰难梭菌患者接受结肠切除术的比例明显高于艰难梭菌阴性患者(44.6% vs. 25%,P = 0.04)。住院时间(11.7 天 vs. 11 天)、初次入院时使用环孢素治疗的比例(48% vs. 47%的患者)和初次入院时需要结肠切除术的比例(23.4% vs. 13.5%)均无统计学意义。

结论

我们的数据表明,患有 UC 发作且感染艰难梭菌的患者比艰难梭菌阴性患者的长期临床结局更差。所有患有 UC 发作的患者都应进行艰难梭菌检测。需要进一步研究阐明感染如何改变 UC 的自然病程。

相似文献

1
Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.溃疡性结肠炎合并艰难梭菌感染患者的临床结局。
Dig Dis Sci. 2010 Feb;55(2):415-20. doi: 10.1007/s10620-009-0749-9. Epub 2009 Mar 3.
2
Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis.艰难梭菌感染与溃疡性结肠炎患者的长期预后较差相关。
J Crohns Colitis. 2012 Apr;6(3):330-6. doi: 10.1016/j.crohns.2011.09.005. Epub 2011 Oct 22.
3
Clostridium difficile infection worsens the prognosis of ulcerative colitis.艰难梭菌感染会使溃疡性结肠炎的预后恶化。
Can J Gastroenterol Hepatol. 2014 Jul-Aug;28(7):373-80. doi: 10.1155/2014/914303.
4
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.炎症性肠病合并艰难梭菌感染患者的联合免疫调节剂与抗生素治疗
Clin Gastroenterol Hepatol. 2009 Sep;7(9):981-7. doi: 10.1016/j.cgh.2009.05.031. Epub 2009 Jun 10.
5
Clostridium difficile infection: a surgical disease in evolution.艰难梭菌感染:一种正在演变的外科疾病。
J Gastrointest Surg. 2008 Sep;12(9):1512-7. doi: 10.1007/s11605-008-0569-9. Epub 2008 Jul 9.
6
Impact of Clostridium difficile infection in patients with ulcerative colitis.艰难梭菌感染对溃疡性结肠炎患者的影响。
J Crohns Colitis. 2011 Feb;5(1):34-40. doi: 10.1016/j.crohns.2010.09.007. Epub 2010 Oct 30.
7
Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis.艰难梭菌相关性结肠炎对溃疡性结肠炎患者 5 年健康结局的影响。
Aliment Pharmacol Ther. 2012 Dec;36(11-12):1032-9. doi: 10.1111/apt.12073. Epub 2012 Oct 14.
8
Recurrence of Clostridium Difficile and Cytomegalovirus Infections in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-Anal Anastomosis.溃疡性结肠炎患者行回肠贮袋-肛管吻合术后艰难梭菌和巨细胞病毒感染的复发。
Dig Dis Sci. 2021 Dec;66(12):4441-4447. doi: 10.1007/s10620-020-06772-8. Epub 2021 Jan 12.
9
Ulcerative colitis worsened after Clostridium difficile infection: efficacy of infliximab.艰难梭菌感染后溃疡性结肠炎病情恶化:英夫利昔单抗的疗效
World J Gastroenterol. 2014 May 7;20(17):5135-40. doi: 10.3748/wjg.v20.i17.5135.
10
Differentiating Clostridium difficile Colitis from Clostridium difficile Colonization in Ulcerative Colitis: A Role for Procalcitonin.鉴别溃疡性结肠炎中艰难梭菌结肠炎与艰难梭菌定植:降钙素原的作用。
Digestion. 2017 Nov;96(4):207-212. doi: 10.1159/000481133. Epub 2017 Oct 14.

引用本文的文献

1
Microbes with higher metabolic independence are enriched in human gut microbiomes under stress.在压力状态下,具有更高代谢独立性的微生物在人类肠道微生物群中富集。
Elife. 2025 May 16;12:RP89862. doi: 10.7554/eLife.89862.
2
Association of infection with clinical outcomes of patients with inflammatory bowel disease: A meta-analysis.炎症性肠病患者感染与临床结局的关联:一项荟萃分析。
World J Gastrointest Surg. 2025 Apr 27;17(4):100555. doi: 10.4240/wjgs.v17.i4.100555.
3
Clinical Outcome of Inflammatory Bowel Disease with Clostridioides difficile Polymerase Chain Reaction Toxin-Positive/Enzyme Immunoassay Toxin-Negative: A Retrospective Cohort Study.

本文引用的文献

1
Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.炎症性肠病患者中与艰难梭菌相关的住院负担过重。
Gut. 2008 Feb;57(2):205-10. doi: 10.1136/gut.2007.128231. Epub 2007 Sep 28.
2
Impact of Clostridium difficile on inflammatory bowel disease.艰难梭菌对炎症性肠病的影响。
Clin Gastroenterol Hepatol. 2007 Mar;5(3):345-51. doi: 10.1016/j.cgh.2006.12.028.
3
Incidence of Clostridium difficile infection in inflammatory bowel disease.炎症性肠病中艰难梭菌感染的发病率
艰难梭菌聚合酶链反应毒素阳性/酶免疫测定毒素阴性的炎症性肠病的临床结局:一项回顾性队列研究
Dig Dis Sci. 2025 Apr 21. doi: 10.1007/s10620-025-09045-4.
4
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study.非达霉素用于炎症性肠病患者艰难梭菌感染的多中心回顾性队列研究。
J Crohns Colitis. 2025 May 8;19(5). doi: 10.1093/ecco-jcc/jjaf056.
5
Analysis of risk factors of infection in patients with inflammatory bowel disease.炎症性肠病患者感染危险因素分析
Prz Gastroenterol. 2024;19(3):277-283. doi: 10.5114/pg.2024.143145. Epub 2024 Sep 18.
6
Genetic insight into the relationship between inflammatory bowel disease and infection.炎症性肠病与感染关系的遗传学研究进展。
mSphere. 2024 Nov 21;9(11):e0056724. doi: 10.1128/msphere.00567-24. Epub 2024 Oct 22.
7
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.感染:历史、流行病学、风险因素、预防、临床表现、治疗和未来选择。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
8
Low prevalence of Clostridioides difficile infection in acute severe ulcerative colitis: A retrospective cohort study from northern India.印度北部一项回顾性队列研究:艰难梭菌感染在急性重度溃疡性结肠炎中发病率较低。
Indian J Gastroenterol. 2023 Jun;42(3):411-417. doi: 10.1007/s12664-022-01336-2. Epub 2023 May 12.
9
Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study.炎症性肠病患者与非炎症性肠病人群中艰难梭菌相关性腹泻的临床结局:一项回顾性队列研究。
Medicine (Baltimore). 2023 Feb 10;102(6):e32812. doi: 10.1097/MD.0000000000032812.
10
Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative Colitis.溃疡性结肠炎患者起始使用维得利珠单抗和抗 TNFα 药物后发生胃肠道感染的风险。
J Clin Gastroenterol. 2023 Aug 1;57(7):714-720. doi: 10.1097/MCG.0000000000001733.
Clin Gastroenterol Hepatol. 2007 Mar;5(3):339-44. doi: 10.1016/j.cgh.2006.12.027.
4
Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.三种快速检测粪便标本中艰难梭菌毒素A和毒素B方法的评估。
Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):115-9. doi: 10.1007/s10096-006-0251-7.
5
The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease.
J Clin Gastroenterol. 2004 Oct;38(9):772-5. doi: 10.1097/01.mcg.0000139057.05297.d6.
6
Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool.炎症性肠病复发时的肠道感染:粪便微生物学检查的重要性
Eur J Gastroenterol Hepatol. 2004 Aug;16(8):775-8. doi: 10.1097/01.meg.0000131040.38607.09.
7
Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.1987 - 2001年美国医院获得性艰难梭菌病的长期趋势
J Infect Dis. 2004 May 1;189(9):1585-9. doi: 10.1086/383045. Epub 2004 Apr 20.
8
Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools.用于粪便中艰难梭菌检测的TOX A/B检测与细胞培养细胞毒性测定法的比较。
Diagn Microbiol Infect Dis. 2000 Apr;36(4):211-3. doi: 10.1016/s0732-8893(00)00113-9.
9
Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile.
J Clin Gastroenterol. 1993 Jan;16(1):26-30. doi: 10.1097/00004836-199301000-00008.
10
Clostridium difficile colitis.艰难梭菌结肠炎
N Engl J Med. 1994 Jan 27;330(4):257-62. doi: 10.1056/NEJM199401273300406.